Sometimes the best days are the ones you do not plan.
As a founder and CEO, there is rarely such a thing as a full day off. When my oldest son was not feeling well and our nanny was away, I found myself with an unexpected day at home with my boys.
I took a few work calls and then brought them to one of my favorite places in Los Angeles, the @TheHuntington . We moved at a slower pace and spent time in the sun.
Research shows that unplanned days off often rank high on the happiness scale. I understand that now.
We do not always get to choose the timing. But sometimes, the interruption is the gift.
It reminded me how important it is to slow down, be present, and truly cherish the time we have with the people who matter most.
Thank you for my amazing team @NeuraSignal for the flexibility on Monday!
Recently I was reminded of a powerful patient story that exemplifies why we at NeuraSignal are so passionate about our work. In this video, meet Michelle Hamilton, whose potential Patent Foramen Ovale (PFO) was missed by the standard of care Transthoracic Echocardiogram (TTE) bubble study. Thanks to our NG2 platform, we were able to accurately detect the issue, leading to a successful PFO closure procedure and a significant reduction in her stroke risk.
Collaborating with our clinical partners to deliver improved outcomes like this is at the heart of what we do—transforming lives through innovative technology in real-world settings.
Importantly, this wasn't part of a clinical study; it was the NG2 platform in action during everyday clinical use, highlighting the value of our commercial solutions in enhancing patient care.
Watch Michelle's story here: https://t.co/vGUROzWlwX
Traveling today I was reminded of a powerful patient story that exemplifies why we at NeuraSignal are so passionate about our work. In this video, meet Michelle Hamilton, whose potential Patent Foramen Ovale (PFO) was missed by the standard of care Transthoracic Echocardiogram (TTE) bubble study. Thanks to our NG2 platform, we were able to accurately detect the issue, leading to a successful PFO closure procedure and a significant reduction in her stroke risk.
Collaborating with our clinical partners to deliver improved outcomes like this is at the heart of what we do—transforming lives through innovative technology in real-world settings.
Importantly, this wasn't part of a clinical study; it was the NG2 platform in action during everyday clinical use, highlighting the value of our commercial solutions in enhancing patient care.
Watch Michelle's story here: https://t.co/vGUROzWlwX
hashtag#Cardiology hashtag#MedTech hashtag#PatientStories hashtag#InnovationInHealthcare hashtag#NeuraSignal
We’re proud to share that data published in Stroke, @StrokeAHA_ASA, show that our NovaGuide Intelligent Ultrasound system was 3X more likely to detect #stroke associated heart defects than standard of care screening diagnostic. Read more at https://t.co/jok6YK7fxQ #NeuraSignal
Please join us in welcoming Anchal Bharti Patel, Senior Director of Customer Operations at NovaSignal. Anchal brings extensive experience leading implementations and customer success in the neurovascular imaging industry. Welcome, Anchal!
Another study confirming that TCD has much better diagnostic utility than TTE for the detection of PFO in patients with recent stroke or TIA. Great presentation by @MarkNRubinMD at the #ISC2022!
@MarkNRubinMD @almuftifawaz@StrokeAHA_ASA@NovaSignal Thank you @MarkNRubinMD for the presentation. I would also like to thank the patients and other investigators for marking this important work possible. @NovaSignal.
NovaSignal is attending ASN in Scottsdale. On 1/13, 5-7pm, check out Corey Thibeault’s abstract "Transcranial Doppler Ultrasound Significantly Improves Identification of Acute Phase Large Vessel" which just received the Best Abstract award! Agenda here: https://t.co/C0hKySVhYV
“The #healthcare industry recognizes the need for faster & more accurate #stroke diagnosis…[Our] platform will improve the standard of care for stroke patients...” https://t.co/HQ8N394vbA via @LABJnews
Last chance to save your seat for our live webinar this Wed, Sep 29,10am Pacific. Presented by Zsolt Garami, MD, this webinar will review the evidence for interoperative monitoring with TCD and examine case studies from the Houston Methodist hospital. https://t.co/kMiZ5rtXc8
“My vision is for the journal to be the premier destination for the latest, state-of-the-art research studies & an important platform for researchers & clinicians to share their findings focused on vascular care,” Proud of my brother @AshuPJadhav inaugural EIC! #SVIN
@DrBapuPod interesting medical/economic question, how does the timing of a pregnancy (within the calendar year) impact the financials given the deductible? Put another way, babies born early in the year are more expensive because you have not got your deductible.
Join us for our upcoming live webinar. Presented by Zsolt Garami, MD, this webinar will review the evidence and utility for interoperative monitoring with TCD and examine case studies from the Houston Methodist hospital. Reserve your spot today! https://t.co/x8rGI3awCV